[{"id":"4e8df9fe-3c59-4aef-9a61-bbf629e2d2be","acronym":"","url":"https://clinicaltrials.gov/study/NCT02600169","created_at":"2021-01-18T12:37:26.205Z","updated_at":"2024-07-02T16:35:05.815Z","phase":"","brief_title":"Retrospective Analysis of Response Markers and Adverse Events in Melanoma Patients Treated With Pembrolizumab","source_id_and_acronym":"NCT02600169","lead_sponsor":"University Medical Center Groningen","biomarkers":" S100B","pipe":"","alterations":" ","tags":["S100B"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Keytruda (pembrolizumab)"],"overall_status":"Completed","enrollment":" Enrollment 150","initiation":"Initiation: 07/01/2015","start_date":" 07/01/2015","primary_txt":" Primary completion: 04/01/2019","primary_completion_date":" 04/01/2019","study_txt":" Completion: 04/01/2019","study_completion_date":" 04/01/2019","last_update_posted":"2024-05-06"},{"id":"3aab3e90-ac52-4a3d-9955-f8be178a5260","acronym":"PBT","url":"https://clinicaltrials.gov/study/NCT05709522","created_at":"2023-02-02T16:00:29.287Z","updated_at":"2024-07-02T16:35:56.562Z","phase":"","brief_title":"Neurocognitive and Psychosocial Outcomes Among Pediatric Brain Tumor and Blood Cancer Patients","source_id_and_acronym":"NCT05709522 - PBT","lead_sponsor":"Aga Khan University","biomarkers":" GFAP • S100B","pipe":"","alterations":" ","tags":["GFAP • S100B"],"overall_status":"Recruiting","enrollment":" Enrollment 80","initiation":"Initiation: 11/20/2020","start_date":" 11/20/2020","primary_txt":" Primary completion: 11/30/2023","primary_completion_date":" 11/30/2023","study_txt":" Completion: 11/30/2023","study_completion_date":" 11/30/2023","last_update_posted":"2023-02-02"},{"id":"95042f6a-45be-4701-aa7b-d23a629aa6c0","acronym":"","url":"https://clinicaltrials.gov/study/NCT01652547","created_at":"2021-01-18T07:07:16.540Z","updated_at":"2024-07-02T16:36:37.035Z","phase":"Phase 1","brief_title":"A Phase I, Exploratory, Intra-patient Dose Escalation Study to Investigate the Preliminary Safety, Pharmacokinetics, and Anti-tumor Activity of Pasireotide (SOM230) s.c.Followed by Pasireotide LAR in Patients With Metastaticmelanoma or Metastatic Merkel Cell Carcinoma","source_id_and_acronym":"NCT01652547","lead_sponsor":"Novartis Pharmaceuticals","biomarkers":" CCND1 • S100B","pipe":"","alterations":" ","tags":["CCND1 • S100B"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Signifor LAR (pasireotide long acting release)"],"overall_status":"Completed","enrollment":" Enrollment 10","initiation":"Initiation: 11/01/2012","start_date":" 11/01/2012","primary_txt":" Primary completion: 04/01/2015","primary_completion_date":" 04/01/2015","study_txt":" Completion: 04/01/2015","study_completion_date":" 04/01/2015","last_update_posted":"2020-12-21"},{"id":"64869ade-a6c9-483a-ac3a-c7d531966c14","acronym":"","url":"https://clinicaltrials.gov/study/NCT01601314","created_at":"2021-01-18T06:50:52.181Z","updated_at":"2024-07-02T16:37:14.756Z","phase":"Phase 3","brief_title":"Perioperative Magnesium Sulphate as a Cerebral Protector in Neurosurgical Patients","source_id_and_acronym":"NCT01601314","lead_sponsor":"Sara Varea","biomarkers":" APOE • S100B","pipe":"","alterations":" ","tags":["APOE • S100B"],"overall_status":"Completed","enrollment":" Enrollment 55","initiation":"Initiation: 10/01/2012","start_date":" 10/01/2012","primary_txt":" Primary completion: 12/01/2017","primary_completion_date":" 12/01/2017","study_txt":" Completion: 12/01/2017","study_completion_date":" 12/01/2017","last_update_posted":"2018-01-17"},{"id":"ae857c70-b6a3-48b4-b193-499c38329501","acronym":"EPIBRAINRAD","url":"https://clinicaltrials.gov/study/NCT02544178","created_at":"2023-08-24T15:09:57.517Z","updated_at":"2024-07-02T16:37:28.937Z","phase":"","brief_title":"Study of Neurological Complication After Radiotherapy for High Grade Glioblastoma","source_id_and_acronym":"NCT02544178 - EPIBRAINRAD","lead_sponsor":"Sophie JACOB","biomarkers":" S100B","pipe":"","alterations":" ","tags":["S100B"],"overall_status":"Unknown status","enrollment":" Enrollment 200","initiation":"Initiation: 04/01/2015","start_date":" 04/01/2015","primary_txt":" Primary completion: 04/01/2018","primary_completion_date":" 04/01/2018","study_txt":" Completion: 04/01/2020","study_completion_date":" 04/01/2020","last_update_posted":"2016-09-22"}]